Other Events ·
On June 22, 2026, shareholders of Wave Life Sciences Ltd. approved a Scheme of Arrangement to facilitate the company's…
WVEWave Life Sciences, Inc.
On June 22, 2026, shareholders of Wave Life Sciences Ltd. approved a Scheme of Arrangement to facilitate the company's redomiciliation. The proposal passed with 155,190,836 shares voting in favor and 78,429 shares voting against. The company will now seek final approval from the High Court of the Republic of Singapore, with the redomiciliation expected to take effect in mid-2026. Wave Life Sciences is a biotechnology company that develops RNA-based therapeutics.